Rimon partner Kenneth Anderson was featured in Billboard in an article covering the AI-vocal dispute involving HAVEN.’s viral track “I Run.” Kenneth noted that the case highlights gaps in today’s laws when it comes to AI-generated voice cloning. He told Billboard it should be “a wake-up call for people to look at the status of…

Rimon Partner Jill Berliner was quoted in a recent Forbes article discussing why an increasing number of American songwriters are switching to the UK’s PRS to handle their song royalties. In the article, Jill highlights two reasons for this shift. She explains, “First, for active touring headliners, PRS has created a ‘concierge’ touring arm called…

We are pleased to share that our client, L&M Healthcare Communications will become part of Fingerpaint Medical’s Medical Communications portfolio, expanding the group’s ability to deliver comprehensive and impactful offerings. This integration reflects a shared vision for the future of healthcare communications, centered on delivering smarter, science-driven services in a rapidly evolving industry. Rimon partner…

We congratulate our client on their recent victory in litigation involving a disgruntled former employee and complex cross border issues. Congratulations to our team, Zheng Liu, Scott Raber, Bob Cocchia and Kendra Orr who represented the Chinese companies. A summary of the case, along with some practical suggestions for foreign companies on what to do…

Rimon is pleased to share that we have a team of attorneys attending the International Bar Association Conference on November 2-7 at the Metro Toronto Convention Centre, Toronto. In addition, Rimon Partner and member of the IBA Asset Recovery Committee, Neal Levin will be speaking at the IBA session, “Can you trust a trust? Treatment…

Dogwood Therapeutics, Inc. (Nasdaq: DWTX) (“Dogwood” or the “Company”), a clinical-stage biotechnology company developing new medicines to treat pain and neuropathy, recently announced that in an all-stock transaction, it has secured a royalty free, global license to develop Serpin Pharma’s intravenous (IV) formulation of SP16 to manage cancer related pain (CRP) including a broad range…

Rimon Managing Partner Juan Zúñiga joined Said Chowdhury, founder of SRC Growth Partner and host of the From Cold 2 Close podcast, to discuss how Rimon’s innovative approach has reshaped the legal industry. In the episode, Juan shares how a tech-enabled, distributed model and partner autonomy have driven Rimon’s rapid growth, taking the firm from…

Bio Green Med Solution, Inc. (Nasdaq: BGMS, Nasdaq: BGMSP) (“Bio Green Med”), formerly Cyclacel Pharmaceuticals, Inc., announced the closing of its previously announced Exchange Transaction with FITTERS Diversified Berhad to acquire Fitters Sdn. Bhd., a Malaysia-based company specializing in fire safety and protection solutions. The acquisition marks a significant step in Bio Green Med’s diversification,…

We are pleased to share that Rimôn Falkenfort has been ranked in Best Lawyers® in Germany 2026 guide. Rimon Falkenfort attorneys were ranked in the areas of Banking & Finance, Employee Benefits Law, Investment Funds, Labor and Employment Law, Litigation, Mergers and Acquisitions Law, Real Estate Law and Tax Law. Best Lawyers® rankings are the…

We are pleased to recognize that Rimon partner Patricia M. Annino, FFI Fellow, for her contribution to Business Families and Family Businesses: The STEP Handbook for Advisers, Third Edition. Patricia co-authored the chapter, “Theories and Models in Family Enterprise Advising,” alongside Judy Green, president of the Family Firm Institute. Read the full FFI feature here…